Seasonal Affective Disorder Market to Surpass US$ 794.6 Million by 2027, At a CAGR of 5.5%, Says Coherent Market Insights
SEATTLE, May 05, 2021, (PHARMIWEB) —
Global Seasonal Affective Disorder Market, by Type (Fall & Winter Seasonal Affective Disorder, Spring & Summer Seasonal Affective Disorder, and Others), by Treatment (Light Therapy, Medications, Psychotherapy, Counselling, and Others), by End User (Hospitals, Clinics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 544.7 million in 2020 and is expected to exhibit a CAGR of 5.5% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
The prevalence of bipolar disorder is driving global seasonal affective disorder market growth
Increase in the number of bipolar disorder cases is boosting the seasonal affective disorder, which is expected to propel growth of the global seasonal affective disorder market. For instance, according to the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, in December 2017, the share of global population with bipolar disorder in 2017 was 0.6% (46 million), amongst which 0.55% were males and 0.65% were females.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4333
Global Seasonal Affective Disorder Market – Impact of Coronavirus (COVID-19) Pandemic
Since the outbreak of the COVID-19 virus in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 67.21 million infected individuals worldwide, as of December 8, 2020.
COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by causing disruption to the distribution channel, and by its financial impact on financial firms and markets. As a result of the lockdown, many countries such as Saudi Arabia, the UAE, Egypt and others are facing problems with drug transportation from one place to another.
Moreover, the COVID-19 epidemic has impacted to the supply of raw materials and strong chemicals, which are used to produce drugs such as seasonal affective disorder treatment drugs, this is expected to hinder the global seasonal affective disorder market growth during the forecast period.
An increase in the number of depression are driving the global seasonal affective disorder market, which are expected to increase global seasonal affective disorder market growth. For instance, according to the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, in December 2017, the share of global population with depression in 2017 was 3.4% (264 million), amongst which 2.7% were males and 4.1% were females.
Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/4333
Some of the key players operating in the global seasonal affective disorder market such as Pfizer, Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sanofi, AbbVie Inc., Eli Lily and Company, Novartis AG, Mylan, Inc., F. Hoffmann-La Roche AG, Bausch Health, Allergan, Koninklijke Philips N.V., Bristol-Myers Squibb, Bayer AG, and Henry Schein Inc., among others.
- Global Seasonal Affective Disorder Market, By Type:
- Fall & Winter Seasonal Affective Disorder
- Spring & Summer Seasonal Affective Disorder
- Global Seasonal Affective Disorder Market, By Treatment:
- Light Therapy
- Global Seasonal Affective Disorder Market, By End User:
- Research Institutes
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/seasonal-affective-disorder-market-3593
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights,
1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
- CDN Newswire